Feature Channels: Blood

Filters close
Released: 3-Sep-2024 11:05 AM EDT
Understanding CAR-T cell therapy for cancer: Mayo Clinic expert explains how it works
Mayo Clinic

For many doctors and researchers, immunotherapy that uses someone’s own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Chimeric antigen receptor T-cell therapy, or CAR-T cell therapy, is one type of immunotherapy. Sometimes likened to a “smart drug” or “living drug,” CAR-T cell therapy relies on genetically modified immune cells to recognize and destroy cancer cells.

Newswise: New anti-cancer ‘degrader’ targets protein essential to infant leukemia
Released: 29-Aug-2024 3:05 PM EDT
New anti-cancer ‘degrader’ targets protein essential to infant leukemia
Van Andel Institute

Scientists have developed a potent anti-cancer compound that inhibits cancer cell growth in a tough-to-treat type of infant leukemia.

Released: 28-Aug-2024 7:00 AM EDT
Presión arterial alta daña los riñones
Mayo Clinic

La hipertensión, también conocida como presión arterial alta, es un problema común que afecta las arterias del cuerpo. Si tiene presión arterial alta, el corazón tiene que trabajar más para bombear la sangre.

Released: 28-Aug-2024 7:00 AM EDT
Pressão alta prejudica os rins
Mayo Clinic

A hipertensão, também conhecida como pressão alta, é um problema comum que afeta as artérias do corpo. Se você tem pressão alta, o coração tem que trabalhar mais para bombear o sangue.

Newswise: FAMU-FSU College of Engineering research shows how insulin, zinc and pH can block harmful protein clumps linked to Type 2 diabetes
Released: 22-Aug-2024 11:05 AM EDT
FAMU-FSU College of Engineering research shows how insulin, zinc and pH can block harmful protein clumps linked to Type 2 diabetes
Florida State University

New research led by Ayyalusamy Ramamoorthy, a professor at the FAMU-FSU College of Engineering and the Florida State University-headquartered National High Magnetic Field Laboratory, shows how zinc, pH levels and insulin work together to inhibit the buildup of protein clumps that contribute to Type 2 diabetes.

   
Released: 20-Aug-2024 8:05 AM EDT
Type 2 diabetes increased by almost 20% over a decade
University of Georgia

Type 2 diabetes increased by almost 20% between 2012 and 2022, according to a new study from the University of Georgia.

Newswise: Medical Oncologists Dr. Anokhi Patel and Dr. Peter Ledakis Guests on Mercy Medical Center's
Released: 19-Aug-2024 5:05 PM EDT
Medical Oncologists Dr. Anokhi Patel and Dr. Peter Ledakis Guests on Mercy Medical Center's "MEDOSCOPY" series
Mercy Medical Center

Medical oncologists Peter Ledakis, M.D. and Anokhi Patel, M.D. of Medical Oncology and Hematology at Mercy are guests of the hospital’s ongoing talk show series, “Medoscopy,” airing on Facebook Watch, Wed.-Thurs., Aug. 21st-22nd at 5:30 p.m. EST (www.facebook.com/MercyMedicalCenter).

Released: 15-Aug-2024 11:05 AM EDT
American Society of Anesthesiologists Brings ANESTHESIOLOGY® 2024 to Philadelphia
American Society of Anesthesiologists (ASA)

Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen may be a simple way to reduce the risk of postoperative delirium. Combining two common blood tests may help doctors identify pregnant women who are at higher risk for life-threatening preeclampsia.

Released: 13-Aug-2024 9:05 AM EDT
Could targeting metabolism treat blood clots in antiphospholipid syndrome? 
Michigan Medicine - University of Michigan

Neutrophils are an important type of white blood cell that help your immune system fight infections.  One of the many ways neutrophils help is by capturing germs in sticky, spider web-like structures called neutrophil extracellular traps, or NETs.However, excessive formation of NETs is seen in many autoimmune diseases as a sign of exuberant inflammation.

Newswise: Children's Hospital Los Angeles Names James F. Amatruda, MD, PhD, As Director Of The Cancer And Bloood Dicease Institute
Released: 13-Aug-2024 6:05 AM EDT
Children's Hospital Los Angeles Names James F. Amatruda, MD, PhD, As Director Of The Cancer And Bloood Dicease Institute
Children's Hospital Los Angeles

Children’s Hospital Los Angeles has named James F. Amatruda, MD, PhD, a highly respected medical leader, clinician, and researcher with global recognitions, as Director of the Cancer and Blood Disease Institute and Alfred E. Mann Family Foundation Chair in Cancer Research at Children’s Hospital Los Angeles

Newswise: Scientists identify genes linked to relapse in the most common form of childhood leukemia
Released: 12-Aug-2024 11:50 AM EDT
Scientists identify genes linked to relapse in the most common form of childhood leukemia
St. Jude Children's Research Hospital

Scientists from St. Jude Children’s Research Hospital, Seattle Children’s and the Children’s Oncology Group (COG) have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood cancer.

Newswise: RandallPrize.JPG
Released: 9-Aug-2024 9:05 AM EDT
MD Anderson recognizes outstanding faculty
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center last night recognized over 100 faculty members at its annual Celebration of Faculty Excellence awards ceremony, acknowledging their compassionate care, exceptional contributions to their fields and the distinction they have brought to the institution.

7-Aug-2024 11:05 AM EDT
Potential New Approach to Enhancing Stem-Cell Transplants
Albert Einstein College of Medicine

A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body’s different blood cells.

Newswise: Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia
Released: 5-Aug-2024 5:05 PM EDT
Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia
St. Jude Children's Research Hospital

Explore how scientists at St. Jude Children’s Research Hospital have identified causes for age-related differences in treatment outcomes of B-cell acute lymphoblastic leukemia.

Newswise: Uncontrolled Hypertension:  The Old ‘Silent Killer’ is Alive and Well
Released: 1-Aug-2024 8:30 AM EDT
Uncontrolled Hypertension: The Old ‘Silent Killer’ is Alive and Well
Florida Atlantic University

High blood pressure affects about 45% of U.S. adults. In the 1970s, only about 50% of patients were aware of their hypertension. Today, 54% are aware of their high blood pressure, 40% are actively treated and 21% are actively controlled. As such, researchers alert health care providers that the old “silent killer” is alive and well.

24-Jul-2024 12:00 PM EDT
New research shows how machine learning could revolutionize diagnosis and treatment of multiple myeloma and sepsis
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Exciting research at the frontier of artificial intelligence and data science in laboratory medicine was presented today at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo).

Newswise: MSK Research Highlights, July 31, 2024
Released: 31-Jul-2024 9:05 AM EDT
MSK Research Highlights, July 31, 2024
Memorial Sloan Kettering Cancer Center

New research from Memorial Sloan Kettering Cancer Center (MSK) showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.

Released: 31-Jul-2024 7:30 AM EDT
Most blood thinner dosing problems happen after initial prescription
Michigan Medicine - University of Michigan

More than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most prescribing issues for DOACs occur after a provider writes the initial prescription. Researchers say the findings highlight why patients on DOACs need to be monitored consistently.



close
2.55719